AMPK would normally activate energy production, and one of its targets is the insulin receptor (IR), whose trafficking interaction with insulin are in turn impaired by the APOE4 human apolipoprotein isoform [117], a well-known risk factor for AD. This evidence concerns the gene APOE and Alzheimer disease.